Jinzi Zheng STTARR Innovation Centre Princess Margaret Cancer Centre Biography Publications Institution JoVE Articles Jinzi Zheng has not added a biography. If you are Jinzi Zheng and would like to personalize this page please email our Author Liaison for assistance. Publications Ambient Mass Spectrometry Imaging with Picosecond Infrared Laser Ablation Electrospray Ionization (PIR-LAESI) Analytical Chemistry. Nov, 2015 | Pubmed ID: 26561279 Longitudinal Tumor Hypoxia Imaging with [(18)F]FAZA-PET Provides Early Prediction of Nanoliposomal Irinotecan (nal-IRI) Treatment Activity EJNMMI Research. Dec, 2015 | Pubmed ID: 26481012 A Multimodal Nano Agent for Image-guided Cancer Surgery Biomaterials. Oct, 2015 | Pubmed ID: 26218742 Evaluation of PET Imaging Performance of the TSPO Radioligand [(18)F]DPA-714 in Mouse and Rat Models of Cancer and Inflammation Molecular Imaging and Biology : MIB : the Official Publication of the Academy of Molecular Imaging. Jul, 2015 | Pubmed ID: 26194010 Cyclophosphamide-Mediated Tumor Priming for Enhanced Delivery and Antitumor Activity of HER2-Targeted Liposomal Doxorubicin (MM-302) Molecular Cancer Therapeutics. Sep, 2015 | Pubmed ID: 26162690 Contrast Agent Mass Spectrometry Imaging Reveals Tumor Heterogeneity Analytical Chemistry. Aug, 2015 | Pubmed ID: 26138213 Whole-body Organ-level and Kidney Micro-dosimetric Evaluations of (64)Cu-loaded HER2/ErbB2-targeted Liposomal Doxorubicin ((64)Cu-MM-302) in Rodents and Primates EJNMMI Research. 2015 | Pubmed ID: 25918676 A Gradient-loadable (64)Cu-chelator for Quantifying Tumor Deposition Kinetics of Nanoliposomal Therapeutics by Positron Emission Tomography Nanomedicine : Nanotechnology, Biology, and Medicine. Jan, 2015 | Pubmed ID: 25200610 Heat-activated Thermosensitive Liposomal Cisplatin (HTLC) Results in Effective Growth Delay of Cervical Carcinoma in Mice Journal of Controlled Release : Official Journal of the Controlled Release Society. Mar, 2014 | Pubmed ID: 24440663 A Mathematical Model of the Enhanced Permeability and Retention Effect for Liposome Transport in Solid Tumors PloS One. 2013 | Pubmed ID: 24312530 The Translocator Protein Radioligand 18F-DPA-714 Monitors Antitumor Effect of Erufosine in a Rat 9L Intracranial Glioma Model Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. Dec, 2013 | Pubmed ID: 24212976 A Novel Minimally Invasive Technique to Create a Rabbit VX2 Lung Tumor Model for Nano-sized Image Contrast and Interventional Studies PloS One. 2013 | Pubmed ID: 23840673 The Translocator Protein Ligand [¹⁸F]DPA-714 Images Glioma and Activated Microglia in Vivo European Journal of Nuclear Medicine and Molecular Imaging. May, 2012 | Pubmed ID: 22270507 APN/CD13-targeting As a Strategy to Alter the Tumor Accumulation of Liposomes Journal of Controlled Release : Official Journal of the Controlled Release Society. Sep, 2011 | Pubmed ID: 21640146 Differential Expression of the 18 KDa Translocator Protein (TSPO) by Neoplastic and Inflammatory Cells in Mouse Tumors of Breast Cancer Molecular Pharmaceutics. Jun, 2011 | Pubmed ID: 21417480 Liposome Contrast Agent for CT-based Detection and Localization of Neoplastic and Inflammatory Lesions in Rabbits: Validation with FDG-PET and Histology Contrast Media & Molecular Imaging. May-Jun, 2010 | Pubmed ID: 20586032 Targeting Focal Adhesion Kinase with Dominant-negative FRNK or Hsp90 Inhibitor 17-DMAG Suppresses Tumor Growth and Metastasis of SiHa Cervical Xenografts Cancer Research. Jun, 2009 | Pubmed ID: 19458065 Quantitative CT Imaging of the Spatial and Temporal Distribution of Liposomes in a Rabbit Tumor Model Molecular Pharmaceutics. Mar-Apr, 2009 | Pubmed ID: 19298061 In Vivo Performance of a Liposomal Vascular Contrast Agent for CT and MR-based Image Guidance Applications Pharmaceutical Research. Jun, 2007 | Pubmed ID: 17373581 Multimodal Contrast Agent for Combined Computed Tomography and Magnetic Resonance Imaging Applications Investigative Radiology. Mar, 2006 | Pubmed ID: 16481918 Medidas espaciais de Perfusão, intersticial pressão do produto e lipossomas Acumulação em tumores sólidos Shawn Stapleton1,2,3, Daniel Mirmilshteyn2, Jinzi Zheng3,4, Christine Allen2,4,5, David A. Jaffray1,2,3,4,5,6 1Department of Medical Biophysics, University of Toronto, 2Leslie Dan Faculty of Pharmacy, University of Toronto, 3STTARR Innovation Centre, Princess Margaret Cancer Centre, 4Institute of Biomaterials and Biomedical Engineering, University of Toronto, 5Techna Institute, University Health Network, 6Radiation Medicine Program, Princess Margaret Cancer Centre Medicine Customizado aparelho de aquecimento à base de laser para lançamento acionado de cisplatina de termossensível lipossomas com Ressonância Magnética Orientação Imagem Yannan N. Dou1, Robert A. Weersink2,5, Warren D. Foltz5,6, Jinzi Zheng5,6, Naz Chaudary7, David A. Jaffray2,3,4,5,6, Christine Allen1 1Leslie Dan Faculty of Pharmacy, University of Toronto, 2Department of Radiation Oncology, University of Toronto, 3Medical Biophysics, University of Toronto, 4Institute of Biomaterials & Biomedical Engineering, University of Toronto, 5Techna Institute and Radiation Medicine Program, Princess Margaret Cancer Center, University Health Network, 6STTARR Innovation Center, University Health Network, 7Ontario Cancer Institute, University Health Network JoVE 53055 Bioengineering
Medidas espaciais de Perfusão, intersticial pressão do produto e lipossomas Acumulação em tumores sólidos Shawn Stapleton1,2,3, Daniel Mirmilshteyn2, Jinzi Zheng3,4, Christine Allen2,4,5, David A. Jaffray1,2,3,4,5,6 1Department of Medical Biophysics, University of Toronto, 2Leslie Dan Faculty of Pharmacy, University of Toronto, 3STTARR Innovation Centre, Princess Margaret Cancer Centre, 4Institute of Biomaterials and Biomedical Engineering, University of Toronto, 5Techna Institute, University Health Network, 6Radiation Medicine Program, Princess Margaret Cancer Centre Medicine
Customizado aparelho de aquecimento à base de laser para lançamento acionado de cisplatina de termossensível lipossomas com Ressonância Magnética Orientação Imagem Yannan N. Dou1, Robert A. Weersink2,5, Warren D. Foltz5,6, Jinzi Zheng5,6, Naz Chaudary7, David A. Jaffray2,3,4,5,6, Christine Allen1 1Leslie Dan Faculty of Pharmacy, University of Toronto, 2Department of Radiation Oncology, University of Toronto, 3Medical Biophysics, University of Toronto, 4Institute of Biomaterials & Biomedical Engineering, University of Toronto, 5Techna Institute and Radiation Medicine Program, Princess Margaret Cancer Center, University Health Network, 6STTARR Innovation Center, University Health Network, 7Ontario Cancer Institute, University Health Network JoVE 53055 Bioengineering